The medical community is intrigued by retatrutide, a novel dual GIP and GLP-1 receptor that’s showing remarkable results in clinical studies . This compound works by imitating natural hormones to affect appetite and increase feelings of fullness , ultimately contributing to considerable body loss . While currently under review and not broadly av… Read More